Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2010 /
Personalising medicine in colorectal cancer

7th - 10th Nov 2010

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.01.11
Views: 5189

Prof Will Steward - University of Leicester, UK

Prof Will Steward discusses the latest treatment options for patients with colorectal cancer. These treatments are only effective in a small proportion of patients, are extremely expensive and are associated with high patient toxicity. Prof Steward explains which criteria can be used to better determine which patients will respond to treatment but identified a lack of reliable molecular predictors as a major weakness. Response to preoperative treatment is a potential way of predicting response to postoperative treatment. Prof Steward talks about how this would work in practice and outlines the benefits of selecting patients more accurately.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation